The global artificial intelligence in genomics services market size was USD 560 million in 2023, estimated at USD 785.12 million in 2024 and is anticipated to reach around USD 20,241.92 million by 2034, expanding at a CAGR of 38.40% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Artificial Intelligence in Genomics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Artificial Intelligence in Genomics Market, by Offering, 2024-2034
8.1.1. Software
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Services
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. Artificial Intelligence in Genomics Market, by Application, 2024-2034
9.1.1. Drug Discovery & Development
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Precision Medicine
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Diagnostics
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Animal Research and Agriculture
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2021-2034)
10.1. Artificial Intelligence in Genomics Market, by End User, 2024-2034
10.1.1. Pharmaceutical & Biotech Companies
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Government Organizations
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Research Organizations
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2021-2034)
11.1. Artificial Intelligence in Genomics Market, by Technology, 2024-2034
11.1.1. Machine Learning
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Other Technologies
11.1.2.1. Market Revenue and Forecast (2021-2034)
12.1. Artificial Intelligence in Genomics Market, by Functionality, 2024-2034
12.1.1. Genome Sequencing
12.1.1.1. Market Revenue and Forecast (2021-2034)
12.1.2. Gene Editing
12.1.2.1. Market Revenue and Forecast (2021-2034)
12.1.3. Clinical Workflows
12.1.3.1. Market Revenue and Forecast (2021-2034)
12.1.4. Predictive Genetic Testing & Preventive Medicine
12.1.4.1. Market Revenue and Forecast (2021-2034)
13.1. North America
13.1.1. Market Revenue and Forecast, by Offering (2021-2034)
13.1.2. Market Revenue and Forecast, by Application (2021-2034)
13.1.3. Market Revenue and Forecast, by End User (2021-2034)
13.1.4. Market Revenue and Forecast, by Technology (2021-2034)
13.1.5. Market Revenue and Forecast, by Functionality (2021-2034)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Offering (2021-2034)
13.1.6.2. Market Revenue and Forecast, by Application (2021-2034)
13.1.6.3. Market Revenue and Forecast, by End User (2021-2034)
13.1.6.4. Market Revenue and Forecast, by Technology (2021-2034)
13.1.7. Market Revenue and Forecast, by Functionality (2021-2034)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Offering (2021-2034)
13.1.8.2. Market Revenue and Forecast, by Application (2021-2034)
13.1.8.3. Market Revenue and Forecast, by End User (2021-2034)
13.1.8.4. Market Revenue and Forecast, by Technology (2021-2034)
13.1.8.5. Market Revenue and Forecast, by Functionality (2021-2034)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Offering (2021-2034)
13.2.2. Market Revenue and Forecast, by Application (2021-2034)
13.2.3. Market Revenue and Forecast, by End User (2021-2034)
13.2.4. Market Revenue and Forecast, by Technology (2021-2034)
13.2.5. Market Revenue and Forecast, by Functionality (2021-2034)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Offering (2021-2034)
13.2.6.2. Market Revenue and Forecast, by Application (2021-2034)
13.2.6.3. Market Revenue and Forecast, by End User (2021-2034)
13.2.7. Market Revenue and Forecast, by Technology (2021-2034)
13.2.8. Market Revenue and Forecast, by Functionality (2021-2034)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Offering (2021-2034)
13.2.9.2. Market Revenue and Forecast, by Application (2021-2034)
13.2.9.3. Market Revenue and Forecast, by End User (2021-2034)
13.2.10. Market Revenue and Forecast, by Technology (2021-2034)
13.2.11. Market Revenue and Forecast, by Functionality (2021-2034)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Offering (2021-2034)
13.2.12.2. Market Revenue and Forecast, by Application (2021-2034)
13.2.12.3. Market Revenue and Forecast, by End User (2021-2034)
13.2.12.4. Market Revenue and Forecast, by Technology (2021-2034)
13.2.13. Market Revenue and Forecast, by Functionality (2021-2034)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Offering (2021-2034)
13.2.14.2. Market Revenue and Forecast, by Application (2021-2034)
13.2.14.3. Market Revenue and Forecast, by End User (2021-2034)
13.2.14.4. Market Revenue and Forecast, by Technology (2021-2034)
13.2.15. Market Revenue and Forecast, by Functionality (2021-2034)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Offering (2021-2034)
13.3.2. Market Revenue and Forecast, by Application (2021-2034)
13.3.3. Market Revenue and Forecast, by End User (2021-2034)
13.3.4. Market Revenue and Forecast, by Technology (2021-2034)
13.3.5. Market Revenue and Forecast, by Functionality (2021-2034)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Offering (2021-2034)
13.3.6.2. Market Revenue and Forecast, by Application (2021-2034)
13.3.6.3. Market Revenue and Forecast, by End User (2021-2034)
13.3.6.4. Market Revenue and Forecast, by Technology (2021-2034)
13.3.7. Market Revenue and Forecast, by Functionality (2021-2034)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Offering (2021-2034)
13.3.8.2. Market Revenue and Forecast, by Application (2021-2034)
13.3.8.3. Market Revenue and Forecast, by End User (2021-2034)
13.3.8.4. Market Revenue and Forecast, by Technology (2021-2034)
13.3.9. Market Revenue and Forecast, by Functionality (2021-2034)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Offering (2021-2034)
13.3.10.2. Market Revenue and Forecast, by Application (2021-2034)
13.3.10.3. Market Revenue and Forecast, by End User (2021-2034)
13.3.10.4. Market Revenue and Forecast, by Technology (2021-2034)
13.3.10.5. Market Revenue and Forecast, by Functionality (2021-2034)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Offering (2021-2034)
13.3.11.2. Market Revenue and Forecast, by Application (2021-2034)
13.3.11.3. Market Revenue and Forecast, by End User (2021-2034)
13.3.11.4. Market Revenue and Forecast, by Technology (2021-2034)
13.3.11.5. Market Revenue and Forecast, by Functionality (2021-2034)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Offering (2021-2034)
13.4.2. Market Revenue and Forecast, by Application (2021-2034)
13.4.3. Market Revenue and Forecast, by End User (2021-2034)
13.4.4. Market Revenue and Forecast, by Technology (2021-2034)
13.4.5. Market Revenue and Forecast, by Functionality (2021-2034)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Offering (2021-2034)
13.4.6.2. Market Revenue and Forecast, by Application (2021-2034)
13.4.6.3. Market Revenue and Forecast, by End User (2021-2034)
13.4.6.4. Market Revenue and Forecast, by Technology (2021-2034)
13.4.7. Market Revenue and Forecast, by Functionality (2021-2034)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Offering (2021-2034)
13.4.8.2. Market Revenue and Forecast, by Application (2021-2034)
13.4.8.3. Market Revenue and Forecast, by End User (2021-2034)
13.4.8.4. Market Revenue and Forecast, by Technology (2021-2034)
13.4.9. Market Revenue and Forecast, by Functionality (2021-2034)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Offering (2021-2034)
13.4.10.2. Market Revenue and Forecast, by Application (2021-2034)
13.4.10.3. Market Revenue and Forecast, by End User (2021-2034)
13.4.10.4. Market Revenue and Forecast, by Technology (2021-2034)
13.4.10.5. Market Revenue and Forecast, by Functionality (2021-2034)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Offering (2021-2034)
13.4.11.2. Market Revenue and Forecast, by Application (2021-2034)
13.4.11.3. Market Revenue and Forecast, by End User (2021-2034)
13.4.11.4. Market Revenue and Forecast, by Technology (2021-2034)
13.4.11.5. Market Revenue and Forecast, by Functionality (2021-2034)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Offering (2021-2034)
13.5.2. Market Revenue and Forecast, by Application (2021-2034)
13.5.3. Market Revenue and Forecast, by End User (2021-2034)
13.5.4. Market Revenue and Forecast, by Technology (2021-2034)
13.5.5. Market Revenue and Forecast, by Functionality (2021-2034)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Offering (2021-2034)
13.5.6.2. Market Revenue and Forecast, by Application (2021-2034)
13.5.6.3. Market Revenue and Forecast, by End User (2021-2034)
13.5.6.4. Market Revenue and Forecast, by Technology (2021-2034)
13.5.7. Market Revenue and Forecast, by Functionality (2021-2034)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Offering (2021-2034)
13.5.8.2. Market Revenue and Forecast, by Application (2021-2034)
13.5.8.3. Market Revenue and Forecast, by End User (2021-2034)
13.5.8.4. Market Revenue and Forecast, by Technology (2021-2034)
13.5.8.5. Market Revenue and Forecast, by Functionality (2021-2034)
14.1. IBM
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. NVIDIA Corporation
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Benevolent AI
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Verge Genomics
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. MolecularMatch, Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. SOPHiA GENETICS
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. PrecisionLife Ltd.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Lifebit
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. FDNA, Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Empiric Logic
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample